Browse EX-10 agreements

***Execution Version ***

TERM LOAN CREDIT AGREEMENT

dated as of

July 15, 2026

Among

BAKER HUGHES HOLDINGS LLC,

as the Borrower,

BAKER HUGHES COMPANY,

as the Parent Guarantor,

The Lenders Party Hereto,

and

UNICREDIT BANK GMBH, NEW YORK BRANCH, as Administrative Agent

$1,000,000,000 TERM LOAN CREDIT FACILITY

UNICREDIT BANK GMBH, NEW YORK BRANCH, as sole Bookrunner and sole Lead Arranger

---

**TABLE OF CONTENTS **

| | | | | | | | | ------------------------------------------ | - | ------------------------------------------------- | : | :--: | -: | - | | | | | | | | | | | | | | Page | | | | | | | | | | |

…

SECURITIES PURCHASE AGREEMENT

This Securities Purchase Agreement (this “Agreement”) is dated as of July 14, 2026, between Cardiff Oncology, Inc., a Delaware corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively the “Purchasers”).

WHEREAS, subject to the terms and conditions set forth in this Agreement and pursuant to an effective registration statement under the Securities Act (as defined below), the Company desires to issue and sell to each Purchaser, and each Purchaser, severally and not jointly, desires to purchase from the Company, securities of the Company as more fully described in this Agreement.

NOW, THEREFORE, IN CONSIDERATION of the mutual covenants contained in this Agreement, and for other good and valuable consideration the receipt and adequacy of which are hereby acknowledged, the Company and each Purchaser agree as follows:

ARTICLE I.

DEFINITIONS

1.1

…

​

​

​

Exhibit 10.1

SEPARATION** **AGREEMENT

This Separation Agreement (this “Agreement”) is entered into by and between Glenn Reicin (“Executive”) andHarmony Biosciences Holdings,Inc. and Harmony Biosciences Management, Inc. (together the “Company”), effective as of July 16, 2026 (the “Effective Date”).

1.Separation.Effective as of July 16, 2026(the “Separation Date”), Executive’s employment with the Company and all of its affiliates shall terminate and Executive shall cease to be an employee of all of the foregoing. The parties hereto acknowledgeandagree that, effectiveas of the Separation Date, (i) thatcertain Employment Agreement, datedas of April 14, 2026,byandbetweenExecutiveandtheCompany(the“Employment Agreement”)shallterminate(exceptasotherwiseexpresslysetforthhereinandtherein)andtheCompany shall have no further obligations under the Employment Agreement; and (ii) Executive shall be deemed to have resigned from all offices and directorships held with the Company and its subsidiaries.

2.Separation* from Employment*.

…

SETTLEMENT AGREEMENT

This SETTLEMENT AGREEMENT (this “Agreement”) is entered into as of this 15th day of July, 2026 (the “Effective Date”), by and between Sadot Group Inc., a Nevada corporation (the “Company”), and Helena Global Investment Opportunities I Ltd., a Cayman Islands exempted company (the “Holder”). The Company and the Holder are each a “Party” and collectively the “Parties.”

RECITALS

…

** **

CERTAIN CONFIDENTIAL PORTIONS OF THIS EXHIBIT WERE OMITTED BY MEANS OF MARKING SUCH PORTIONS WITH BRACKETS (“[***]”) BECAUSE THE IDENTIFIED CONFIDENTIAL PORTIONS (I) ARE NOT MATERIAL AND (II) FORUM MARKETS, INCORPORATED CUSTOMARILY AND ACTUALLY TREATS THAT INFORMATION AS PRIVATE OR CONFIDENTIAL.

ENGINE SALE AND PURCHASE AGREEMENT

Dated as of July 13, 2026

BETWEEN

AERO ENGINE SOLUTIONS, INC.

as Seller

and

EURUS AEROSPACE TOKEN I LLC

as Buyer

with respect to the sale and purchase of one (1) CFM International model CFM56-7B aircraft engine bearing manufacturer’s serial number [***]

ENGINE SALE AND PURCHASE AGREEMENT

**THIS ENGINE SALE AND PURCHASE AGREEMENT **(this “Agreement”) is dated as of this 13th day of July 2026 and entered into by and between:

…

July 15, 2026

Lindsay Androski
Via E-mail

Re: Special Bonus Awards

Dear Lindsay:

Arbutus Biopharma, Inc. (together with Arbutus Biopharma Corporation, “Arbutus”) is writing to inform you of your eligibility to receive the following special cash bonus awards on the terms and conditions set forth in this letter agreement (this “Agreement”). Each of the payments described in the first three paragraphs of this Agreement is subject to the terms and conditions set forth in the fourth, fifth and sixth paragraphs of this Agreement.

…

TERMINATION AGREEMENT

** **

This TERMINATION AGREEMENT (this “Termination Agreement”) is entered into as of July 15, 2026 (the “Termination Agreement Effective Date”), by and between Arbutus Biopharma Corporation, a British Columbia corporation (“Arbutus”), and Genevant Sciences GmbH, a limited liability company organized and existing under the laws of Switzerland (“Genevant”). Arbutus and Genevant may be referred to herein individually as a “Party” and together as the “Parties.”

RECITALS

WHEREAS, the Parties entered into that certain Agreement, dated as of March 2, 2025 (the “mRESVIA Agreement”), regarding the treatment of any recovery from Moderna, Inc. and its affiliates (together, “Moderna”) in the Parties’ patent infringement litigation against Moderna (as described more fully in the mRESVIA Agreement, the “Patent Litigation”) specifically allocated to Moderna’s vaccine marketed as mRESVIA®;

…

---

Exhibit 10.1

Execution Version

VOTING AND SUPPORT AGREEMENT

THIS VOTING AND SUPPORT AGREEMENT (this “Agreement”) is made and entered into as of July 15, 2026, by and between Eli Lilly and Company, an Indiana corporation (“Parent”), and the undersigned holder (the “Stockholder”) of common stock, par value $0.01 per share, of AtaiBeckley Inc., a Delaware corporation (the “Company”, and such shares of common stock, the “Company Shares”). Capitalized terms used herein and not defined shall have the meanings ascribed to them in the Agreement and Plan of Merger, dated as of July 15, 2026 by and among Parent, Albali Acquisition Corporation, a Delaware corporation and an indirect wholly owned Subsidiary of Parent (“Merger Sub”), and the Company (the “Merger Agreement”).

…

Certain identified information has been excluded from this exhibit both because it (i) is not material and (ii) is the type that the issuer treats as private or confidential. Brackets with triple asterisks denote omissions.

BRIDGE CREDIT AGREEMENT

Dated as of July 16, 2026

among

UBER TECHNOLOGIES, INC.,
as the Borrower,

MORGAN STANLEY SENIOR FUNDING, INC.,
as Administrative Agent,

and

The Other Lenders Party Hereto

MORGAN STANLEY SENIOR FUNDING, INC.,
BofA SECURITIES, INC. and
DEUTSCHE BANK SECURITIES INC.,
as
Joint Lead Arrangers and Joint Bookrunners

BofA SECURITIES, INC. and
DEUTSCHE BANK SECURITIES INC.
as Syndication Agents

TABLE OF CONTENTS

…

**FORM OF **

SECURITIES EXCHANGE AGREEMENT

This Securities Exchange Agreement** **(this “Agreement”), dated as of July 15, 2026 (the “Effective Date”), is entered into by and between ASP Isotopes Inc., a Delaware corporation (the “Company”), Quantum Leap Energy LLC, a Delaware limited liability company (“QLE”), and the person or entity identified on the signature page hereto (the “Holder”).

RECITALS

WHEREAS, the Company, QLE and the Holder are executing and delivering this Agreement in reliance upon the exemption from securities registration afforded by Section 4(a)(2) of the Securities Act of 1933, as amended (the “Securities Act”), or Rule 506(b) of Regulation D (“Regulation D”) promulgated by the United States Securities and Exchange Commission (the “SEC”) under the Securities Act;

…

FORM of Support AGREEMENT

This SUPPORT AGREEMENT (this “Agreement”) is made as of July 10, 2026, by and among INTERNATIONAL STEM CELL CORPORATION, a Delaware corporation (“Parent”), Lifeline Cell Technologies, LLC, California limited liability company (“Target”), AMERICAN TYPE CELL COLLECTION, INC., a District of Columbia corporation (“Purchaser”), and the Person set forth on Schedule A hereto ( “Stockholder”).

…

MEMBERSHIP INTEREST PURCHASE AGREEMENT

by and among

RON G. SCOTT, an individual and

PROGRESSIVE CARE, LLC, a Nevada Limited Liability Company

dated as of July 14, 2026

Exhibits

Exhibit A          Form of Noncompetition Agreement

Exhibit B          Form of Assignment of Membership Interests

Exhibit C          Form of Powers of Attorney

Exhibit D          Disclosure Schedules

MEMBERSHIP INTEREST PURCHASE AGREEMENT

THIS MEMBERSHIP INTEREST PURCHASE AGREEMENT (this “Agreement”) is entered into as of the 14th day of July, 2026 (the “Effective Date”) by and among PROGRESSIVE CARE, LLC, a Nevada limited liability company (the “Purchaser”), and RON G. SCOTT, an individual (the “Seller”) for the purchase of 100% of the membership interests in SCOTT’S PHARMACY, LLC, a Florida limited liability company (the "Company") (Purchaser and Seller are from time to time referred to individually as a “Party” and collectively as the “Parties”) as follows:

Background Statement

…